Aspen Pharmacare Holdings

Aspen Pharmacare Holdings (SAR) and Nanolek, biopharmaceutical company in Kirov, signed an additional agreement on the localization of the production of injection coagulants for thrombosis prophylaxis and treatment in the Kirov Oblast.

By the end of 2017, the technology will be fully transferred to the plant. A full cycle will be started in 2018.

16 March 2016
Kirov Region

Investor profile

Aspen Pharmacare Holdings


Company's website:


Public company

Contact: Stephen Bradley Saad, Executive Director

The largest African pharmaceutical company